Further in vitro and in vivo experiments performed in the presence of agents neutralizing endogenous (tumor cell-derived or mouse) TRAIL will help to understand the cellular function of TRAIL-R2 in its different cellular compartments as a promoter of skeletal metastasis of breast cancer cells. Here, TNFRSF10B is linked to breast carcinoma.